Capricor Therapeutics
CAPR
#8196
Rank
ยฃ0.25 B
Marketcap
ยฃ4.44
Share price
-3.26%
Change (1 day)
-4.28%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2026 (TTM): -ยฃ97.05 Million

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ78.67 Million a decrease over its 2024 earnings that were of -ยฃ30.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ97.05 Million23.37%
2025 -ยฃ78.67 Million159.57%
2024 -ยฃ30.31 Million81.57%
2023 -ยฃ16.7 Million-23.2%
2022 -ยฃ21.74 Million44.93%
2021 -ยฃ15 Million46.61%
2020 -ยฃ10.23 Million78.71%
2019 -ยฃ5.73 Million-49.7%
2018 -ยฃ11.38 Million-724.78%
2017 ยฃ1.82 M-112.93%
2016 -ยฃ14.09 Million46.27%
2015 -ยฃ9.63 Million106.82%
2014 -ยฃ4.66 Million-48.41%
2013 -ยฃ9.03 Million977.23%
2012 -ยฃ0.84 Million-77.11%
2011 -ยฃ3.66 Million-22.35%
2010 -ยฃ4.72 Million-20.17%
2009 -ยฃ5.91 Million-41.17%
2008 -ยฃ10.04 Million41.05%
2007 -ยฃ7.12 Million1098.87%
2006 -ยฃ0.6 Million4101.55%
2005 -ยฃ0.02 Million-0.97%
2004 -ยฃ0.02 Million17.87%
2003 -ยฃ0.02 Million3.66%
2002 -ยฃ0.02 Million-30.11%
2001 -ยฃ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.62 B-20,351.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.61 B-732.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-ยฃ0.67 Billion 590.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.25 Billion 151.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ4.68 Million-95.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ12.38 Million-87.23%๐Ÿ‡บ๐Ÿ‡ธ USA